Try our mobile app
Screener
Company
Price and
change
Revenue Growth
last / hist
EV /
LTM
EBITDA
(p75)
EV/
Sales
EBITDA LTM
/ Revenue
FCF LTM
/ Revenue
Next GAAP report
Year div-d yield
FCF Yield LTM
200.0%  /
16.9%
6.3x
6.4x
0.8x
12.7%
3.2%
..
4.2%
7.0% 
-11.0%  /
12.9%
4.3x
6.8x
0.5x
12.5%
-4.2%
..
3.2%
-10.2% 
-0.4%  /
7.4%
10x
11.2x
1x
9.4%
5.5%
..
5.5%
7.1% 
10.9%  /
6.9%
11.5x
15.3x
1.6x
13.8%
-3.3%
..
0.0%
-4.9% 
9.7%  /
6.7%
14x
12.8x
2.1x
14.8%
11.3%
2026-11-07
3.5%
5.5% 
14.7%  /
6.1%
14.9x
14.1x
2.7x
18.2%
-14.4%
2026-11-06
2.2%
-6.3% 
47.7%  /
5.3%
8.5x
10.9x
1.2x
14.6%
6.6%
..
2.0%
10.5% 
6.0%  /
5.1%
11.8x
12.5x
2.3x
19.8%
-9.1%
2027-02-06
1.3%
-4.0% 
-4.2%  /
3.4%
6x
9.4x
1.3x
21.3%
4.7%
..
4.2%
6.8% 
-6.1%  /
2.4%
3.4x
8.6x
0.4x
13.0%
3.4%
..
0.0%
3 255.0% 
-6.2%  /
1.2%
6x
7.2x
0.8x
13.8%
-3.1%
..
0.0%
-24.5% 
2.0%  /
-1.7%
10.3x
10.2x
1.9x
17.9%
9.3%
..
1.0%
8.1% 
-20.3%  /
-8.3%
>200x
>200x
0.5x
-4.2%
-0.3%
..
0.0%
-17.4% 
-84.4%  /
-21.9%
32.8x
12.1x
4x
12.0%
21.6%
..
2.0%
6.9% 
Trending screeners:
@electric-vehicles
@saas
@cannabis-players
@china
Latin America
India
Dividends
@REITs
@adtech
@airlines
@artificial-intelligence
@auto-parts
@cloud-computing
@crypto
@cybersecurity
@e-commerce
@edtech
@finance-and-technology
@gaming
@internet-of-things
@oil-refining
@real-estate-tech
@renewable-energy
@vaccine-makers

Reviews

2026-11-06
#reports #ISTR

[Investar Corporation](https://eninvs.com/all.php?name=ISTR) (Banks — Regional) reported for 2026 q3
(2026-04-16, After Market Close):

- Revenue +120.8% YoY (vs +140.9% in previous quarter and historical rate +38.2%)
- Net Income +100% YoY (vs +125.0% in previous quarter and historical rate +34.0%)
- Net Income margin 22.6% decreased compared to 25.0% same period last year
- P/E multiple is 9.8x compared to historical level (75th percentile) of 12.1x
- P/S multiple is 2.1x
- Price to book: 1.3x
2026-11-06
#reports #IRWD

[Ironwood Pharmaceuticals](https://eninvs.com/all.php?name=IRWD) (Drug Manufacturers — Specialty and Generic) reported for 2026 q3
(2026-05-07, Before Market Open):

- Revenue +9% YoY (vs +32.9% in previous quarter and historical rate +5.1%)
- EBITDA +23.7% YoY (vs +77.8% in previous quarter and historical rate +37.9%)
- EBITDA margin 70.7% increased compared to 62.3% same period last year
- EV/EBITDA multiple is 4.9x compared to historical level (75th percentile) of 7.1x
- EV/Sales multiple is 3.1x

2026-11-06
#reports #IOVA

[Iovance Biotherapeutics](https://eninvs.com/all.php?name=IOVA) (Anti-cancer immunotherapies manufacturer) reported for 2026 q3
(2026-05-07, Before Market Open):

- Revenue +80.6% YoY (vs +65.0% in previous quarter and historical rate +85.1%)
- EBITDA margin -11.6% increased compared to -128.4% same period last year
- EV/Sales multiple is 2.6x

2026-11-06
#reports #ICUI

[ICU Medical](https://eninvs.com/all.php?name=ICUI) (Peripheral venous catheter producer) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue +4.3% YoY (vs +0.5% in previous quarter and historical rate -0.7%)
- EBITDA +56.9% YoY (vs +48.3% in previous quarter and historical rate +11.3%)
- EBITDA margin 18.2% increased compared to 12.1% same period last year
- Net Debt decreased by $83 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.9% of market cap
- EV/EBITDA multiple is 16.2x compared to historical level (75th percentile) of 19.6x
- EV/Sales multiple is 2.3x

2026-11-06
#reports #ICFI

[ICF International](https://eninvs.com/all.php?name=ICFI) (Coach) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue +1.1% YoY (vs -0.4% in previous quarter and historical rate -2.2%)
- EBITDA +1.9% YoY (vs -3.6% in previous quarter and historical rate +4.2%)
- EBITDA margin 11.5% has not changed compared to 11.4% same period last year
- Net Debt decreased by $35 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0.3 bln (positive), 14.8% of market cap
- EV/EBITDA multiple is 10.5x compared to historical level (75th percentile) of 17.4x
- EV/Sales multiple is 1.1x

2026-11-06
#reports #HSTM

[HealthStream](https://eninvs.com/all.php?name=HSTM) (Health Information Services) reported for 2026 q3
(2026-05-04, After Market Close):

- Revenue +9.2% YoY (vs +13.5% in previous quarter and historical rate +5.9%)
- EBITDA 0% YoY (vs +17.6% in previous quarter and historical rate +8.6%)
- EBITDA margin 21.7% decreased compared to 23.7% same period last year
- EV/EBITDA multiple is 12.2x compared to historical level (75th percentile) of 14.3x
- EV/Sales multiple is 2.6x

2026-11-06
#reports #HCAT

[Health Catalyst](https://eninvs.com/all.php?name=HCAT) (Software provider) reported for 2026 q3
(2026-05-11, After Market Close):

- Revenue -26.3% YoY (vs -13.6% in previous quarter and historical rate -1.7%)
- EBITDA margin 107.1% increased compared to -6.6% same period last year
- Net Debt decreased by $130 mln over the past reporting period (113.8% of market cap)
- FCF (LTM) +$0 bln (positive), 10.5% of market cap
- EV/Sales multiple is 0.2x

2026-11-06
#reports #HALO

[Halozyme Therapeutics](https://eninvs.com/all.php?name=HALO) (Medicines provider) reported for 2026 q3
(2026-05-11, After Market Close):

- Revenue +39.3% YoY (vs +47.5% in previous quarter and historical rate +42.1%)
- EBITDA +33.5% YoY (vs +39.6% in previous quarter and historical rate +35.4%)
- EBITDA margin 59.8% decreased compared to 62.4% same period last year
- Net Debt increased by $236 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0.9 bln (negative), 6.6% of market cap
- EV/EBITDA multiple is 24.2x compared to historical level (75th percentile) of 20x
- EV/Sales multiple is 9x

2026-11-06
#reports #HAE

[Haemonetics Corporation](https://eninvs.com/all.php?name=HAE) (Medical equipment developer) reported for 2026 q3
(2026-05-07, Before Market Open):

- Revenue +9.5% YoY (vs +5.6% in previous quarter and historical rate +3.9%)
- EBITDA +8.4% YoY (vs +2.4% in previous quarter and historical rate +8.5%)
- EBITDA margin 28.8% decreased compared to 29.1% same period last year
- Net Debt decreased by $88 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.3 bln (positive), 4.4% of market cap
- EV/EBITDA multiple is 22x compared to historical level (75th percentile) of 18.1x
- EV/Sales multiple is 4.7x

2026-11-06
#reports #GMED

[Globus Medical](https://eninvs.com/all.php?name=GMED) (Medical equipment developer) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue -0.7% YoY (vs +6.0% in previous quarter and historical rate +43.9%)
- EBITDA +19.2% YoY (vs +71.4% in previous quarter and historical rate +64.4%)
- EBITDA margin 32.5% increased compared to 27.0% same period last year
- EV/EBITDA multiple is 10.8x compared to historical level (75th percentile) of 30.5x
- EV/Sales multiple is 3.3x

2026-11-06
#reports #GH

[Guardant Health](https://eninvs.com/all.php?name=GH) (Medicine services provider) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue +36.2% YoY (vs +44.4% in previous quarter and historical rate +33.7%)
- EBITDA margin -34.1% increased compared to -35.1% same period last year
- Net Debt increased by $21 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.2% of market cap
- EV/Sales multiple is 16.7x

2026-11-06
#reports #GEL

[Genesis Energy](https://eninvs.com/all.php?name=GEL) (Oil and Gas Midstream) reported for 2026 q3
(2026-05-07, Before Market Open):

- Revenue +8.5% YoY (vs +41.1% in previous quarter and historical rate -10.7%)
- EBITDA -4.3% YoY (vs +34.6% in previous quarter and historical rate +1.6%)
- EBITDA margin 29.4% decreased compared to 33.3% same period last year
- EV/EBITDA multiple is 7.8x compared to historical level (75th percentile) of 11x
- EV/Sales multiple is 2.5x

2026-11-06
#reports #FUN

[Cedar Fair](https://eninvs.com/all.php?name=FUN) (Leisure) reported for 2026 q3
(2026-05-07, Before Market Open):

- Revenue -11% YoY (vs -7.0% in previous quarter and historical rate +27.3%)
- EBITDA -11.4% YoY (vs -6.2% in previous quarter and historical rate +13.9%)
- EBITDA margin 41.0% decreased compared to 41.2% same period last year
- Net Debt decreased by $214 mln over the past reporting period (22.4% of market cap)
- FCF (LTM) +$0.4 bln (positive), 37.5% of market cap
- EV/EBITDA multiple is 9.6x compared to historical level (75th percentile) of 12.3x
- EV/Sales multiple is 2x

2026-11-06
#reports #FSBC

[Five Star Bancorp](https://eninvs.com/all.php?name=FSBC) (Banks — Regional) reported for 2026 q3
(2026-07-22, After Market Close):

- Revenue +21.5% YoY (vs +18.0% in previous quarter and historical rate +28.7%)
- Net Income +37.5% YoY (vs +26.7% in previous quarter and historical rate +23.1%)
- Net Income margin 27.8% increased compared to 24.6% same period last year
- P/E multiple is 13.8x compared to historical level (75th percentile) of 10.7x
- P/S multiple is 3.8x
- Price to book: 2.4x
2026-11-06
#reports #FNKO

[Funko](https://eninvs.com/all.php?name=FNKO) (Vinyl figurine manufacturer) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue +2.8% YoY (vs +7.8% in previous quarter and historical rate -5.7%)
- EBITDA +42.9% YoY (vs +3700.0% in previous quarter and historical rate +64.7%)
- EBITDA margin 11.6% increased compared to 8.4% same period last year
- Net Debt decreased by $8 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) +$0.1 bln (positive), 22.3% of market cap
- EV/EBITDA multiple is 6x compared to historical level (75th percentile) of 20.2x
- EV/Sales multiple is 0.6x

2026-11-06
#reports #FLT

[FleetCor Technologies](https://eninvs.com/all.php?name=FLT) (Digital payment solution provider) reported for 2026 q3
(2024-02-07, After Market Close):

- Revenue +17.9% YoY (vs +21.5% in previous quarter and historical rate +13.2%)
- EBITDA +19.6% YoY (vs +3.5% in previous quarter and historical rate +13.9%)
- EBITDA margin 53.3% increased compared to 52.6% same period last year
- Net Debt increased by $707 mln over the past reporting period (3.6% of market cap)
- FCF (LTM) +$1.3 bln (positive), 6.9% of market cap
- EV/EBITDA multiple is 10.1x compared to historical level (75th percentile) of 14.1x
- EV/Sales multiple is 5.3x

At the opening of the session the share price went down -7.4%
2026-11-06
#reports #FLL

[Full House Resorts](https://eninvs.com/all.php?name=FLL) (Resorts and Casinos) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue +5.1% YoY (vs +5.4% in previous quarter and historical rate +15.4%)
- EBITDA 0% YoY (vs +18.2% in previous quarter)
- EBITDA margin 17.1% decreased compared to 17.9% same period last year
- Net Debt increased by $2 mln over the past reporting period (7.4% of market cap)
- FCF (LTM) +$0 bln (positive), 29.8% of market cap
- EV/EBITDA multiple is 10.4x compared to historical level (75th percentile) of 17.9x
- EV/Sales multiple is 1.7x

2026-11-06
#reports #FLGT

[Fulgent Genetics](https://eninvs.com/all.php?name=FLGT) (Platform for automatic data analysis) reported for 2026 q3
(2026-05-01, Before Market Open):

- Revenue +7.1% YoY (vs +3.7% in previous quarter and historical rate +5.1%)
- EBITDA margin -17.8% decreased compared to -10.7% same period last year
- Net Debt increased by $262 mln over the past reporting period (50.1% of market cap)
- FCF (LTM) -$0.3 bln (negative), 61.7% of market cap
- EV/Sales multiple is 0.8x

2026-11-06
#reports #FA

[First Advantage Corporation](https://eninvs.com/all.php?name=FA) (Specialty Business Services) reported for 2026 q3
(2026-05-07, Before Market Open):

- Revenue +13.9% YoY (vs +14.8% in previous quarter and historical rate +36.9%)
- Net Income +566.7% YoY (vs +50.0% in previous quarter and historical rate +17.8%)
- Net Income margin 4.3% increased compared to 0.7% same period last year
- P/E multiple is 94.7x compared to historical level (75th percentile) of 502.8x
- P/S multiple is 2.3x
- Price to book: 3.1x
2026-11-06
#reports #EVCM

[EverCommerce Inc.](https://eninvs.com/all.php?name=EVCM) (Software — Infrastructure) reported for 2026 q3
(2026-05-07, After Market Close):

- Revenue +2.7% YoY (vs +2.7% in previous quarter and historical rate -2.1%)
- EBITDA -15.2% YoY (vs +3.1% in previous quarter and historical rate +11.4%)
- EBITDA margin 18.5% decreased compared to 22.4% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 5.3% of market cap
- EV/EBITDA multiple is 15.5x compared to historical level (75th percentile) of 21.6x
- EV/Sales multiple is 3.1x

2026-11-06
#reports #EVC

[Entravision Communications Corporation](https://eninvs.com/all.php?name=EVC) (Broadcasting) reported for 2026 q3
(2026-05-05, After Market Close):

- Revenue +86.8% YoY (vs +125.7% in previous quarter and historical rate +12.9%)
- EBITDA margin 12.4% increased compared to -7.4% same period last year
- Net Debt decreased by $12 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 6.1% of market cap
- EV/EBITDA multiple is 8.3x compared to historical level (75th percentile) of 27.7x
- EV/Sales multiple is 1x